Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
1.880
+0.090 (5.03%)
At close: Sep 18, 2026, 4:00 PM EDT
1.870
-0.010 (-0.53%)
After-hours: Sep 18, 2026, 7:51 PM EDT
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $42.64 million as of September 18, 2026. Its market cap has decreased by -19.09% in one year.
Market Cap
42.64M
Enterprise Value
306.07M
1-Year Change
-19.09%
Ranking
Category
Stock Price
$1.88
ChartMarket Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $42.64M, a decrease of -90.37%. That is a compound annual growth rate of -16.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 42.60M | -66.06% |
| Dec 31, 2025 | 125.50M | 48.17% |
| Dec 31, 2024 | 84.70M | -14.53% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
| Nov 6, 2013 | 442.90M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mereo BioPharma Group | 46.33M |
| Grace Therapeutics | 44.81M |
| Metagenomi Therapeutics | 42.69M |
| Seres Therapeutics | 40.76M |
| Veru Inc. | 40.75M |
| CervoMed | 38.55M |
| Actinium Pharmaceuticals | 37.42M |
| aTyr Pharma | 36.93M |